# 



## 



## 

## 

## 

## 

## 

## 

## 

## 



## 

## 



## 

## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 



## 

## 

## 



## 

## 




## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 



## 

## 

## 



## 

|YEAR ENDED 31 MARCH|2023|||||||
|---|---|---|---|---|---|---|---|
||||Unrestricted|Designated|Restricted||Total|
||||f.||5||2|
|Income 8 Endowments<br>from:||Notes||||||
|Donations<br>&legacies||4|3,625|58,793|189,519||251,937|
|Investments||5|72,103|18,462|37,852||128,417|
|TOTAL Incame &Endowments|||75728|77255|227 371||380354|
|Expenditure<br>on:||||||||
|Investraent<br>Management|Costs||22,035|5,643|11,569||39,250|
|Charitable<br>activities|||149,523|79,596|564,813||793,932|
|TOTAL Expenditure|||171,581|85,239|576,382||833,182|
|Net lasses on investment|||(223,221)|(57,154)|(117,184)|(397,559)||
|Net expenditure|||319054|65138|466195||650387|
|Transfers<br>between funds||||||||
|Net movement<br>in funds|||319054|85138|466195||850387|
|Reconciliation ofFunds:||||||||
|Total funds brought<br>forward||11|3,067,250|1,595,029|2,414,749|7,077,028||
|TOTAL Funds carried forward|||2,748,196|1,529,891|1,948,554|6,226,641||
|YEAR ENDED 31 MARCH|2022|||||||
||||Unrestricted<br>f|Designated<br>8|Restricted<br>5||Total|
|Income 8 Endowments<br>from:||Notes||||||
|Donations<br>&legacies||4|90|87,500|1,033,403|1,120,993||
|Investments||5|95,509|16,209|62,014||173,732|
|TOTAL Income &Endawmeras|||95,599|103,709|1,095,417|1,294,725||
|Expenditure<br>on:||||||||
|Investment<br>Management|Costs||28,658|4,864|18,608||52,130|
|Charitable<br>activities|||79,108|22,179|37,941||139,226|
|TOTAL Expenditure|||107765|27043|55549||191358|
|Net gains/(lasses)<br>on investment|||204,428|34,694|132,734||S71,856|
|Net income/(expenditure)|||192,261|111,350|1 171,602|1|7522S|
|Transfers<br>between funds||||||||
|Net movement<br>In funds|||192261|111360|1 171602|1|475223|
|Reconciliation<br>ofFunds:||||||||
|Total funds brought<br>forward||11|2,874,989|1,483,669|1,243,147|5,801,805||
|TOTAL Funds carried forward|||3,067,250|1,595,029|2,414,749|7,077,028||





## 

|||||2023|2022|
|---|---|---|---|---|---|
|Fixed Assets:|||Note|||
|Investments<br>TOTAL Fixed Assets||||6,284,500<br>8,887,375<br>6286,<br>3 ~||
|Current assets:||||||
|Debtors||||21,329|224,548|
|Accrued Income||||3,944|8,680|
|Cash at bank and|in hand|||168,565|12740|
|TOTAL Current Assets||||63.838|5968|
|Liabilities:||||||
|Creditors: amounts|falling|due within one year|10|(251,697)|(36,315)|
|Net Current Assets||||251,697|20|
|TOTAL Assets less|Current|Liabilities|||7677028|
|TOTAL Net Assets|||||7677028|
|The Funds ofthe Charity:||||||
|Unrestricted<br>funds||||2,748,196|3,087,250|
|Designated<br>funds||||1,529,891|1,595,029|
|Restricted funds||||1,948,554|2,414,749|
|TOTAL Funds||||6,226,641|7,077,028|






## 

|TATEMENT OF CASH <br>r the year ended 31 March 2023|F|L|OW|S||||||
|---|---|---|---|---|---|---|---|---|---|
||||||||2023||2022|
|||||||Note|6||6|
|Cash flows from operating<br>activities:<br>Net cash (used in) provided<br>by operating|activities|||||||~2979953||
|Cash flows from investing<br>activities:||||||||||
|Dividends,<br>interest and rents from investments|||||||125,267||173,025|
|Proceeds from sale of investment|||||||1,737,273||4,162237|
|Purchase<br>of investments|||||||(1,674,695)||(1,609,410)|
|Net cash provided<br>by investing<br>activities|||||||187,845||2,525,853|
|Change<br>in cash and cash equivalents<br>in the||reporting||period||||||
|Cash and cash equivalents<br>at the beginning||of|the reporting||period|(ii)|280,510||674,611|
|Cash and cash equivalents<br>at the end ofthe||mporting||period|||313,598||280510|
||||||||2023||2022|
|(i)<br>Reconciliation<br>of net income/(expenditure)|||to net cash||||6||6|
|flow from operating<br>activities:||||||||||
|Net (expenditure)/income<br>for the reporting<br>Statement of Financial Activities)|||period|(as|per the||(850,387)||1,475,223|
|Dividends,<br>interest and rents from investments|||||||(125,267)||(173,025)|
|Losses/(Gains)<br>on investments|||||||397,559||(371,856)|
|Working capital movements:||||||||||
|(Increase)/decrease<br>m debtom|||||||207,955||(181,593)|
|Increase/(decrease)<br>in creditors<br>Net cash (used in) provided<br>by operating|activities||||||215,383<br>~5757|~,|(3,668,703)<br>3979953|
|(il)<br>Analysis ofcash and cash equivalents||||||||||
|Cash at bank and<br>in hand|||||||166,565||12,740|
|Cash held as part ofinvestment<br>portfolio|||||||145,031||267,770|
|TOTAL cash and cash equivalents|||||||3 3589||895 9|





## 

## 

## 

## 



## 

## 

## 

## 

## 



## 

## 

## 

## 

## 



## 

|4|DONATIONS<br>I5 LEGACIES|||||
|---|---|---|---|---|---|
|||Unrestricted<br>E|Designated<br>E|Restricted|2023f|
||Donations|3,625||10,000|13,625|
||Legacies||58,793|179,519|238,312|
|||3,625|58,793|189,519|251,937|
|||Unrestricted|Designated|Restricted|2022|
||Donations|90|||90|
||Legacies||87,500|1,033,403|1,120,903|
|||90|87,500|1,033,403|1,120,993|
|5|INVESTMENTINCOME|||||
|||Unrestricted|Designated|Restricted|2023|
||||5|||
||Income from securities|39,813|10,194|20,901|70,908|
||Interest receivable|32,290|8,268|16,951|57,509|
|||72,103|18,462|37,852|128,417|
|||Unrestricted|Designated|Restdcted|2022|
|||||E|5|
||income from securities|62,080|10,536|40,308|112,924|
||interest receivable|33,040|5,607|21,454|60,101|
||Tax receivable|389|66|252|707|
|||95,509|16,209|62,014|173,732|





||||Unrestrictedf|Designatedf|Restrictedf|2023f|
|---|---|---|---|---|---|---|
|Investment|Management|Costs|22,038|5,643|11,569|39,250|
||||22,038|5,643|11,569|39,250|
||||Unrestnctedf|Designated|Restricted|2022|
|Investment|Management|Costs|28,658|4,864|18,608|52,130|
||||28,658|4,864|18,608|52,130|



## 

|Analysis ofex|pen|diture<br>on charitable|activities|||
|---|---|---|---|---|---|
||||Grant funding<br>of|Support costs|2023|
||||activities|||
||||F|||
|Grants to National||Theatre|592,954|27,246|620,200|
|Grants to Other|Institutions||50,000|2,297|52,297|
|Benevolent Grants|||76,100|3,497|79,597|
|Awards|||40,000|1,838|41,838|
||||759054|34,878|793,932|
||||Grant funding of|Support costs|2022|
||||activitiesf|||
|Grants to National||Theatre|62,550|16,558|79,108|
|Grants to Other|institutions|||||
|Benevolent Grants|||17,158|4,542|21,700|
|Apprenticeship|Support||379|100|479|
|Awards|||30,000|7,941|37,941|
||||110,087|29,141|139,228|





|(b) Analysis ofSupport Costs|||||||
|---|---|---|---|---|---|---|
||National|Other|Benevolent|Apprentice|Awards|2023|
||Theatre|Institutions|Grants|Support|||
||5|5||8|||
|Governance|12,243|1,032|1,571||826|15,672|
|NT Management|||||||
|Charge|14,061|1,186|1,805||948|18,000|
|Finance|919|77|118|||1,176|
|Other|23|||||30|
||27248|2,297|3,497||1,838|34,878|
||National|Other|Benevolent|Appn:ntice|Awanfs|2022|
||Theatref|Institutions|Grants|Support|||
|Governance|5,564||1,526|34|2,669|9,793|
|NTManagement|10,228||2,806|61|4,905|18,000|
|Charge|||||||
|Finance|766||210||367|1,348|
||16,558||4,542|100|7,941|29,141|



## 




## 

||||||Grants|to||Grants to|Support|2022|
|---|---|---|---|---|---|---|---|---|---|---|
||||||institutions||individuals||costs||
||National Theatre||||||||||
||National Theatre Welfare Grant||||50,000||||13,236|63,236|
||National Theatre|Voice Research||Project|12,550||||3,322|15,872|
||Awards||||30,000||||7,941|37,941|
||Other||||||||||
||Benevolent<br>Grants|||||||17,158|4,542|21,700|
||Apprenticeship|Support||||||379|100|479|
||||||92,550|||17,537|29,141|139,228|
|8|INVESTMENTS||||||||||
||(a) Movement<br>in fixed asset investments||||||||||
||||||||||2023f|2022f|
||Market Value at||||||||||
||Beginning ofYear|||||||6,867,375||9,235,442|
||New Money Invested||||||||450,824|932,906|
||Reinvested<br>Income||||||||129,983|180,867|
||Amounts<br>extracted|||||||(726,000)||(3,798,000)|
||Investment<br>management||fees paid|in year|||||(40,123)|(55,696)|
||Increase<br>in value|of investments||||||(397,559)||371,856|
||Market Value at|End ofYear||||||6|284500|6,867,375|
||At the 31 March|2023, all|funds were held with||Rathbone|Investment||Management|Ltd.||
||(b) Investments|at Market Value||comprised:|||||||
||||||||||2023|2022|
||Fixed Interest|||||||1,577,614||1,551,304|
||Equities|||||||4,284,605||4,763,911|
||Property||||||||130,892|160,421|
||Commodities||||||||146,358|123,969|
||Cash||||||||145,031|267,770|
||Market Value at|End ofYear||||||6|284500|6,867,375|





## 

|9<br>DEBTORS|||||
|---|---|---|---|---|
||||2023|2022|
||||E'||
|Trade debtors|||21,329|223,841|
|Accrued Income|||3,944|8,680|
|Other debtors||||707|
||||25,273|233,228|
|10 CREDITORS: AMOUNTS||FALLING DUE WITHIN ONE YEAR|||
|(a) Creditors: amounts||falling due within one year|||
||||2023|2022|
|Accruals for grants payable|||185,504|12,550|
|Trade creditors|||36,915|5,280|
|Accruals and deferred|income||29,278|17,105|
|Other Creditors||||1,380|
||||251,897|39,315|



## 

|(b) Grant commit|ments|||||
|---|---|---|---|---|---|
||Brought|forward|Paid in year|Committed<br>in|Carried forward|
|||||year||
|||||E||
|Awards||12,550|(586,100)|759,054|185,504|
|||12,550|(586,100)|759,054|185,504|





## 

|11 ANALYSIS OF FUNDS|||||||
|---|---|---|---|---|---|---|
|YEAR ENDED 31 MARCH 2023|||||||
||Fund|Income|Expenditure|Transfers|Gains and|Fund|
||balances||||losses|balances|
||brought|||||carried|
||forward|||||forward|
|Unrestricted<br>Funds:|||||||
|General<br>Fund|3,067,250|75,728|(171,561)||(223,221)|2,748,196|
|Designated<br>Funds:|||||||
|Benevolent<br>Fund|1,000,000||(79,596)|79,596||1,000,000|
|Foundation<br>General|||||||
|Purposes<br>Fund|595,029|77,255|(5,643)|(79,596)|(57,154)|529,891|
|Restricted<br>Funds:|||||||
|Restricted<br>Income|||||||
|NT Learning|609,441|8,164|(2,495)||(25,276)|589,834|
|NT Studio/New<br>Work|10,025|182|(55)||(562)|9,590|
|NT General Purpose|1,795,283|219,025|(573,832)||(91,346)|1,349,130|
|Total Funds|7077028|380354|833182||39'7559|6226 641|
|YEAR ENDED 31 MARCH 2022|||||||
||Fund|income|Expenditure|Transfers|Gains and|Fund|
||balances||||losses|balances|
||bmught|||||carried|
||forward|||||forward|
|Unrestricted<br>Funds:|||||||
|General<br>Fund|2,874,989|95,599|(107,766)||204,428|3,067,250|
|Designated<br>Funds:|||||||
|Benevolent<br>Fund|1,000,000||(22,179)|22,179||1,000,000|
|Foundation<br>General|483,669|103,709|(4,864)|(22,179)|34,694|595,029|
|Purposes<br>Fund|||||||
|Restricted Funds:|||||||
|Restricted<br>Income|||||||
|NT Learning|535,274|26,112|(7,835)||55,890|609,441|
|NT Studio/New<br>Work|9,545|169|(51)||362|10,025|
|NT General Purpose|698,328|1,069,136|(48,663)||76,482|1,795,283|
|Total Funds|5,601,805|1,294,725|(191,358)||371,856|7,077,028|





## 

## 



## 

|YEAR ENDED|31 MARCH 2023|31 MARCH 2023|||||
|---|---|---|---|---|---|---|
||||Unrestricted|Designated|Restricted|Total|
||||Funds|Funds|Funds|Funds|
|Investments||Asset|3,815,200|973,851|1,495,449|6,284,500|
|Current|Assets||(926,494)|563,512|556,820|193,838|
|Current|Liabilities||(140,510)|(7,472)|(103,715)|(251,697)|
||||2,748,196|1,529,891|1,948,554|6,226,641|
|YEAR ENDED 31 MARCH||2022|Unrestricted|Designated|Restricted|Total|
||||Funds|Funds|Funds|Funds|
||||||Z||
|Investments|Assets||3,776,022|1,018,086|2073,267|6,867,375|
|Cunenl Assets|||(691,484)|589,493|347,959|245,968|
|Current Liabilities|||(17,288)|(12,550)|(6,477)|(36,315)|
||||3,057,250|1,595,029|2,414,749|7,077,028|



## 

## 

